Posts Tagged ‘FDA’

Medical roundup

  • “Judge Says He’s Had Enough Of Weeding Through Baseless Lawsuits, Threatens Sanctions” [Daniel Fisher; M. D. Georgia judge on vaginal mesh cases]
  • More on pricey regulated generics [Scott Gottlieb/WSJ, earlier on EpiPen, more on latter from Joel Zinberg/City Journal]
  • Feds ban pre-dispute arbitration agreements in nursing home care [McKnights]
  • How Ronald Reagan’s FDA responded to the AIDS crisis — and it’s probably not the story you’ve heard [Peter Huber, City Journal]
  • FDA regs likely to winnow smaller, distinctive makers from the cigar business, recalling a Somerset Maugham story [James M. Patterson] Debunking the “Helena miracle,” once more: no link between local smoking bans and short-term drops in heart attacks [Jacob Sullum, earlier here and here]
  • “Ethicists make the case for bone marrow transplantation markets” [Ilya Somin]

“The FDA cultivates a coterie of journalists whom it keeps in line with threats”

Charles Seife in Scientific American tells the story of how, using the “close-hold embargo” and other techniques, the Food and Drug Administration (FDA) and other government agencies shape what you read about them when major initiatives and findings are announced. I sum up highlights in my new Cato post. More: Megan McArdle.

Medical roundup

  • FDA to dental consumers: you can’t handle the tooth [New York Times via Alex Tabarrok]
  • “How lawyers scare people out of taking their meds” [Lisa Rickard (U.S. Chamber), Washington Post]
  • Lawsuits fail to bring improvements to nursing homes [ABA Journal]
  • Everything,” new Institute for Justice short film about costs of regulating bone marrow donation, has upcoming screenings in D.C. area, Breckinridge, Colo. and elsewhere;
  • Aetna pulls out of most ObamaCare exchanges, and the acrimony flies [WSJ editorial] “Did the Medicaid expansion limit labor force participation?” [Tomas Wind via Tyler Cowen]
  • Posting will be slower in coming weeks as I conduct my own in-person investigation of the state of America’s medical system. Thanks for bearing with me!

“Scott Alexander” on the EpiPen affair

“When was the last time that America’s chair industry hiked the price of chairs 400% and suddenly nobody in the country could afford to sit down?” Funny, isn’t it, how these episodes keep happening in a sector of the economy where a new competitor, before being allowed to enter even a well-understood generic market, faces the prospect of unpredictable and expensive government denials and delays? [Scott Alexander]

More: Scott Gottlieb on how the new, more ardently regulatory FDA keeps generic drugs (and devices) off the market. Don’t blame the patent angle; EpiPen is off-patent [Timothy Holbrook, The Conversation]

Food and nanny state roundup

  • Has Obama administration endorsed anti-GMO campaign with new labeling law? Not really [Thomas Firey, Cato, earlier here, here, etc.]
  • United Nations anti-tobacco meeting seeks to exclude persons overly involved with tobacco production, ban list turns out to include many officials of member governments [Huffington Post UK]
  • Dumping Michigan tart cherries to comply with USDA marketing order? There must be a better way [Baylen Linnekin]
  • “I am the man, the very fat man, who waters the workers’ beer.” [Science Daily, prompting Christopher Snowdon’s recollection of that line of song]
  • Feds alone have spent $500 million chasing food-desert mirage, with “negligible” impact on health [Mac McCann, Dallas News, earlier]
  • “FDA Assigns Zero Value To Smokers Who Die Because Of Its E-Cigarette Regulations” [Jacob Sullum, more on vaping]

August 3 roundup

FDA issues menu labeling mandate

Vaping isn’t the only issue on which the Food and Drug Administration has stopped its ears to distress cries from the regulated community. It has now followed through with a stringent rather than lenient version of the menu labeling concept mandated by the ObamaCare law, one that will extend coverage to doubtful areas including some restaurant coupons and advertisements and ensure burdensome compliance issues for variety items such as toppings on pizza or ice cream. [CS News, Elizabeth Harrington/Free Beacon, earlier]

The FDA’s war on vaping

I’ve got a new piece at Ricochet on the Food and Drug Administration’s just-announced measures against vaping (e-cigarettes), which will drastically restrict and maybe even ban a popular option for smokers seeking to quit the cigarette habit. It’s not just an assault on individual choice and commercial freedom — it could wind up killing people. Read it here.

Relatedly, Andrew Stuttaford thinks I am too kind in describing CDC director Thomas Frieden as in denial about the prospective health benefits when smokers switch to vaping. And thank you to Andrew for describing Overlawyered as “must-read”.

P.S. Faced with two options on how to regulate premium cigars, FDA chose the harsher, of course [HalfWheel, Jacob Grier (“The market for cigars is about to become a lot less diverse and a lot more boring.”)]

More: I’ve got a piece up at Cato now on winners and losers from the FDA’s move. Plus, a new Jacob Sullum column: “The FDA’s deadly e-cigarette regulations.” And a Washington Post editorial defends the agency’s action on a for-the-children rationale, yet says not a word about the precipitous plunge in youth smoking rates and only refers in passing to the issue of harm reduction.

May 4 roundup

  • New gun store in Arlington, Va., just outside D.C., sues neighbors as well as officials who tried to block its opening [Washington Post]
  • Good: “Amendment Could Save the Vaping Industry From Prohibitive FDA Regulations” [Jacob Sullum]
  • N.J.: “Bergen County Father Jailed For Non-Payment Of Support For Kids Who Live With Him” [Bergen Dispatch via Hans Bader]
  • Outrage over state override of local regulatory options seems to depend a lot on whose ox is gored [Aaron Renn, Urbanophile]
  • That way, they could challenge it in court? Claim that businesses would be better off if DOJ went ahead and issued regulations commanding their websites to have ADA “accessibility” [Legal NewsLine, earlier]
  • “Washington Redskins Appeal To SCOTUS On Trademark And Seek To Tie Their Case To That Of The Slants” [Timothy Geigner, TechDirt, earlier]